Company intelligence / Profile preview

Tranalab

Bangalore, Karnataka, India

Ownership: Private
Development stage: Other

Overview

Tranalab is developing macrophage-targeted delivery technology using macrophage-targeting molecules for drug conjugation or genetic encoding into biologics; company is at pre-clinical proof-of-concept stage for expression systems and targeted therapeutics.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

JLABS (Johnson & Johnson Innovation Center - Shanghai) incubator

Beyond the preview

Go deeper on Tranalab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tranalab.

Explore the full profile